Home LiteratureArticle Details
PMID: 8215255 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro.

Annals of neurology ·Vol. 34 ·No. 4 ·1993-10-00 ·Pages 631-3

Wisniewski T, Castano E, Ghiso J, Frangione B

Abstract

Alzheimer's disease is characterized by the deposition of beta-protein (A beta) as amyloid. Recently, it was found that A beta is a normal component of serum and cerebrospinal fluid. Synthetic peptides homologous to A beta form amyloid-like fibrils spontaneously in water or physiological solutions. Using a peptide homologous to A beta 1-40, we find that fibril formation is inhibited by the presence of cerebrospinal fluid.

MeSH Terms
Alzheimer Disease/metabolism Amino Acid Sequence Amyloid/biosynthesis Amyloid beta-Peptides/biosynthesis Cerebrospinal Fluid/metabolism Humans Molecular Sequence Data Peptides/metabolism
Chemicals
Amyloid Amyloid beta-Peptides Peptides
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wisniewski T
Department of Pathology, New York University Medical Center, NY 10016.
Castano E
Ghiso J
Frangione B
Article Info
Journal
Annals of neurology
Abbr.
Ann Neurol
ISSN
0364-5134
Published
1993-10-00
Pages
631-3
Language
English
Region
United States
NLM ID
7707449
Subset
IM
Grants
NIA NIH HHS · AG10953 · United States
NIAMS NIH HHS · AR02594 · United States
NIA NIH HHS · KO8AG00542-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com